"Arrr, the swift nod fer new TKI in CML be raisin' a hullabaloo, matey! What be goin' on here?"
2024-12-02
Arrr, savvy matey! The treasure of tyrosine kinase potions be givin’ us hearty choices for CML, stirrin’ doubts 'bout the US givin' a quick nod to asciminib as the captain of the crew! Aye, what a jolly ruckus it be! <i>Medscape Medical News</i>
Ahoy mateys! Gather 'round as I spin ye a yarn about them newfangled tyrosine kinase inhibitors that be settin' sail in the treacherous waters of chronic myeloid leukemia, or CML for short. Aye, these advancements be givin’ us a fine treasure chest of options, makin’ the ol’ scallywags wonder about the swift approval o' asciminib for the frontline battle against this fearsome foe.